Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?

Detalles Bibliográficos
Autores principales: Deng, Jie-Lin, Jiang, Yun-Qiu, Guo, Yan-Kai, Li, Hong-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647493/
https://www.ncbi.nlm.nih.gov/pubmed/32804730
http://dx.doi.org/10.1097/CM9.0000000000000996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647493/
https://www.ncbi.nlm.nih.gov/pubmed/32804730
http://dx.doi.org/10.1097/CM9.0000000000000996

Ejemplares similares